Volume 11, Number 9—September 2005
Dispatch
Human Herpesvirus 8 and Pulmonary Hypertension
Emanuele Nicastri*
, Carmine Dario Vizza†, Fabrizio Carletti*, Stefania Cicalini*, Roberto Badagliacca†, Roberto Poscia†, Giuseppe Ippolito*, Francesco Fedele†, and Nicola Petrosillo*
, Carmine Dario Vizza†, Fabrizio Carletti*, Stefania Cicalini*, Roberto Badagliacca†, Roberto Poscia†, Giuseppe Ippolito*, Francesco Fedele†, and Nicola Petrosillo*
Table
Human herpesvirus 8 (HHV-8) seroprevalence among candidate patients for lung transplantation
| Diagnosis | Patients | Female sex (%) | Median age (range) | HHV-8 seroprevalence (%) |
|---|---|---|---|---|
| Patients with pulmonary hypertension | ||||
| Idiopathic pulmonary arterial hypertension | 16 | 14 (87.5) | 46 (28–74) | 1 (6.3) |
| Secondary pulmonary hypertension | 17 | 11 (64.7) | 44 (22–65) | 0 (0) |
| Patients without pulmonary hypertension | ||||
| Cystic fibrosis | 29 | 9 (31.0) | 23 (14–28) | 5 (17.2) |
| Interstitial lung disease | 13 | 3 (23.1) | 47 (43–74) | 3 (23.1) |
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.